STOCKWELL LYNN (CEO & Exe. Chair of the Board) made both purchases and sales at DRUGS MADE IN AMERICA ACQUISITION II CORP.
Purchased 4.9% of their position (700K shares) and sold 54.3% of their position (7.97M shares) — review individual transaction dates and prices for directional context.
P · 1S · 1
Filed: 10/1/2025ACC: 0001213900-25-094436
DirectorOfficer10% Owner· CEO & Exe. Chair of the Board
Since Sep 2025
-6.97M
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
1B · 1S
4
Total transactions
1.40M acquired · 8.37M disposed
Non-Derivative Transactions3
Ordinary shares
Indirect
Shares
+700K
Price / share
—
Trade value
—
% of position
4.9%
9/26/2025
14.38M→15.07M
Ordinary shares
Indirect
Shares
−400K
Price / share
—
Trade value
—
% of position
2.7%
9/26/2025
15.07M→14.68M
Ordinary shares
Indirect
Shares
−7.97M
Price / share
—
Trade value
—
% of position
54.3%
9/26/2025
14.68M→6.71M
Total
Net shares
−7.67M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary shares Indirect | 9/26/2025 | P · Purchase | +700K | — | — | 4.9% | 14.38M | 15.07M |
| Ordinary shares Indirect | 9/26/2025 | J · J | −400K | — | — | 2.7% | 15.07M | 14.68M |
| Ordinary shares Indirect | 9/26/2025 | S · Sale | −7.97M | — | — | 54.3% | 14.68M | 6.71M |
| Total | −7.67M | $0.00 | ||||||
Derivative Transactions1
Rights to receive ordinary shares
Indirect
Converts to
Ordinary shares
70K shares
Shares
+700K
Strike price
Held after
700K
Exercisable
—
9/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Rights to receive ordinary shares Indirect | Ordinary shares70K shares | 9/26/2025 | P · Purchase | +700K | — | 700K |